TY  - JOUR

T1  - Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK

JO  - Osteoporosis International

UR  - http://dx.doi.org/10.1007/s00198-024-07251-w

PY  - 2024/10/04

AU  - Borgström F

AU  - Lorentzon M

AU  - Johansson H

AU  - Harvey NC

AU  - McCloskey E

AU  - Willems D

AU  - Knutsson D

AU  - Kanis JA

ED  - 

DO  - DOI: 10.1007/s00198-024-07251-w

PB  - Springer Science and Business Media LLC

Y2  - 2024/12/22

ER  -